Tapewire

Nasdaq · USD

CDNA

CareDx, Inc.

Export transactions ↓
Tapewire entity
4344
SEC CIK
0001217234
Parsed reports
707

Last 12 months

Inside the activity.

0 purchase rows · 26 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202502
Jan 202603
Feb 202601
Mar 202600
Apr 202601
May 202603
Jun 202606
Jul 202604
Aug 202605
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 03, 2019 Filed May 3, 2019 20:58 UTC
King SashaChief Commercial Officer
SaleCommon Stock 1,250 $29.50 $36,875.00
Disclosure

SEC source: 0000899243-19-012103 · doc4.xml · nonDerivative · entry 3

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,594

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
May 03, 2019 Filed May 3, 2019 20:58 UTC
King SashaChief Commercial Officer
Exercise / conversionCommon Stock 417 $6.31 $2,631.27
Disclosure

SEC source: 0000899243-19-012103 · doc4.xml · nonDerivative · entry 2

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,844

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
May 03, 2019 Filed May 3, 2019 20:58 UTC
King SashaChief Commercial Officer
Exercise / conversionCommon Stock 833 $5.90 $4,914.70
Disclosure

SEC source: 0000899243-19-012103 · doc4.xml · nonDerivative · entry 1

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,427

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
April 17, 2019 Filed Apr 18, 2019 23:52 UTC
Maag PeterDirector · See Remarks
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 14,931 $0.00 Strike: $2.80 $0.00
Disclosure

SEC source: 0000899243-19-010921 · doc4.xml · derivative · entry 8

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,069

Underlying: Common Stock · 14,931 shares

Expires 2027-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: 50% of the shares subject to the option vested on September 1, 2018 and 1/72nd of the shares subject to the option vest monthly thereafter.

Read SEC document
April 17, 2019 Filed Apr 18, 2019 23:52 UTC
Maag PeterDirector · See Remarks
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 30,245 $0.00 Strike: $2.30 $0.00
Disclosure

SEC source: 0000899243-19-010921 · doc4.xml · derivative · entry 7

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,500

Underlying: Common Stock · 30,245 shares

Expires 2027-02-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 27, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
April 17, 2019 Filed Apr 18, 2019 23:52 UTC
Maag PeterDirector · See Remarks
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 4,824 $0.00 Strike: $5.49 $0.00
Disclosure

SEC source: 0000899243-19-010921 · doc4.xml · derivative · entry 6

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,334

Underlying: Common Stock · 4,824 shares

Expires 2024-11-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option vest in three equal installments based upon the Issuer's achievement of certain performance goals as follows: (i) one third vest upon the Issuer's determination, which has been reviewed by the Issuer's independent registered public accounting firm, that the Issuer has achieved $10 million of total cumulative sales of Allosure, its proprietary next-generation sequencing-based test to detect donor-derived, cell-free DNA after transplantation, commencing after the completion of the offer by the Issuer to exchange certain outstanding stock options for new options as more fully described in the Schedule TO-I, filed with the Securities Exchange Commission on October 12, 2017, as amended, and supplemented on October 24, 2017 and November 9, 2017 (the "Exchange Offer"), (ii) one third vest upon the Issuer's determination,

F4 · derivative.exercise_date: (Continued from footnote 3) which has been reviewed by the Issuer's independent registered public accounting firm, that the Issuer has achieved quarterly revenues of at least $18.75 million for two consecutive fiscal quarters commencing after the completion of the Exchange Offer, and (iii) one third vest in the event the closing sales price of the Issuer's common stock is at or above $5.00 per share, as quoted by NASDAQ, for 10 consecutive trading days after the completion of the Exchange Offer.

Read SEC document
April 17, 2019 Filed Apr 18, 2019 23:52 UTC
Maag PeterDirector · See Remarks
Exercise / conversionCommon Stock 14,931 $2.80 $41,806.80
Disclosure

SEC source: 0000899243-19-010921 · doc4.xml · nonDerivative · entry 3

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 488,406

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
April 17, 2019 Filed Apr 18, 2019 23:52 UTC
Maag PeterDirector · See Remarks
Exercise / conversionCommon Stock 30,245 $2.30 $69,563.50
Disclosure

SEC source: 0000899243-19-010921 · doc4.xml · nonDerivative · entry 2

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 473,475

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
April 17, 2019 Filed Apr 18, 2019 23:52 UTC
Maag PeterDirector · See Remarks
Exercise / conversionCommon Stock 4,824 $5.49 $26,483.76
Disclosure

SEC source: 0000899243-19-010921 · doc4.xml · nonDerivative · entry 1

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 443,230

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 01:33 UTC OtherWarrant (right to buy) · Derivative 4,415 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0000899243-19-010853 · doc4.xml · derivative · entry 3

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,415 shares

Expires 2023-06-17

Read SEC document
April 16, 2019 Filed Apr 18, 2019 01:33 UTC OtherCommon Stock 4,415 $1.12 $4,944.80
Disclosure

SEC source: 0000899243-19-010853 · doc4.xml · nonDerivative · entry 1

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,382

Read SEC document
April 15, 2019 Filed Apr 18, 2019 01:33 UTC PurchaseWarrant (right to buy) · Derivative 4,415 $28.26 Strike: $1.12 $124,767.90
Disclosure

SEC source: 0000899243-19-010853 · doc4.xml · derivative · entry 2

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,415

Underlying: Common Stock · 4,415 shares

Expires 2023-06-17

Read SEC document
April 12, 2019 Filed Apr 12, 2019 19:48 UTC
King SashaChief Commercial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 5,833 $0.00 Strike: $6.31 $0.00
Disclosure

SEC source: 0000899243-19-010617 · doc4.xml · derivative · entry 11

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,167

Underlying: Common Stock · 5,833 shares

Expires 2028-01-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
April 12, 2019 Filed Apr 12, 2019 19:48 UTC
King SashaChief Commercial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 4,167 $0.00 Strike: $5.90 $0.00
Disclosure

SEC source: 0000899243-19-010617 · doc4.xml · derivative · entry 10

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,833

Underlying: Common Stock · 4,167 shares

Expires 2027-10-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: 1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
April 12, 2019 Filed Apr 12, 2019 19:48 UTC
King SashaChief Commercial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 416 $0.00 Strike: $2.80 $0.00
Disclosure

SEC source: 0000899243-19-010617 · doc4.xml · derivative · entry 9

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,028

Underlying: Common Stock · 416 shares

Expires 2027-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 50% of the shares subject to the option vested on September 1, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
April 12, 2019 Filed Apr 12, 2019 19:48 UTC
King SashaChief Commercial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,041 $0.00 Strike: $1.07 $0.00
Disclosure

SEC source: 0000899243-19-010617 · doc4.xml · derivative · entry 8

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,417

Underlying: Common Stock · 1,041 shares

Expires 2027-06-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 25% of the shares subject to the option vested on June 9, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
April 12, 2019 Filed Apr 12, 2019 19:48 UTC
King SashaChief Commercial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,250 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0000899243-19-010617 · doc4.xml · derivative · entry 7

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 1,250 shares

Expires 2027-04-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 25% of the shares subject to the option vested on March 30, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
April 12, 2019 Filed Apr 12, 2019 19:48 UTC
King SashaChief Commercial Officer
SaleCommon Stock 10,000 $29.81 $298,064.00
Disclosure

SEC source: 0000899243-19-010617 · doc4.xml · nonDerivative · entry 6

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,594

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $31.43, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
April 12, 2019 Filed Apr 12, 2019 19:48 UTC
King SashaChief Commercial Officer
Exercise / conversionCommon Stock 5,833 $6.31 $36,806.23
Disclosure

SEC source: 0000899243-19-010617 · doc4.xml · nonDerivative · entry 5

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,594

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
April 12, 2019 Filed Apr 12, 2019 19:48 UTC
King SashaChief Commercial Officer
Exercise / conversionCommon Stock 4,167 $5.90 $24,585.30
Disclosure

SEC source: 0000899243-19-010617 · doc4.xml · nonDerivative · entry 4

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,761

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
April 12, 2019 Filed Apr 12, 2019 19:48 UTC
King SashaChief Commercial Officer
Exercise / conversionCommon Stock 416 $2.80 $1,164.80
Disclosure

SEC source: 0000899243-19-010617 · doc4.xml · nonDerivative · entry 3

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,594

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
April 12, 2019 Filed Apr 12, 2019 19:48 UTC
King SashaChief Commercial Officer
Exercise / conversionCommon Stock 1,041 $1.07 $1,113.87
Disclosure

SEC source: 0000899243-19-010617 · doc4.xml · nonDerivative · entry 2

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,178

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
April 12, 2019 Filed Apr 12, 2019 19:48 UTC
King SashaChief Commercial Officer
Exercise / conversionCommon Stock 1,250 $1.00 $1,250.00
Disclosure

SEC source: 0000899243-19-010617 · doc4.xml · nonDerivative · entry 1

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,137

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
April 12, 2019 Filed Apr 12, 2019 23:48 UTC
Maag PeterDirector · See Remarks
SaleCommon Stock 100,000 $29.11 $2,910,530.00
Disclosure

SEC source: 0000899243-19-010618 · doc4.xml · nonDerivative · entry 1

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 438,406

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.31 to $31.51, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
April 09, 2019 Filed Apr 10, 2019 01:43 UTC
Maag PeterDirector · See Remarks
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 2,255 $0.00 Strike: $2.30 $0.00
Disclosure

SEC source: 0000899243-19-010428 · doc4.xml · derivative · entry 8

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,745

Underlying: Common Stock · 2,255 shares

Expires 2027-02-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 27, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
April 09, 2019 Filed Apr 10, 2019 01:43 UTC
Maag PeterDirector · See Remarks
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 35,381 $0.00 Strike: $5.27 $0.00
Disclosure

SEC source: 0000899243-19-010428 · doc4.xml · derivative · entry 7

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,369

Underlying: Common Stock · 35,381 shares

Expires 2026-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 22, 2017 and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
April 09, 2019 Filed Apr 10, 2019 01:43 UTC
Maag PeterDirector · See Remarks
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 42,364 $0.00 Strike: $6.49 $0.00
Disclosure

SEC source: 0000899243-19-010428 · doc4.xml · derivative · entry 6

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 42,364 shares

Expires 2025-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 21, 2016 and 1/48th of the shares subject to the option vested monthly thereafter.

Read SEC document
April 09, 2019 Filed Apr 10, 2019 01:43 UTC
Maag PeterDirector · See Remarks
Exercise / conversionCommon Stock 2,255 $2.30 $5,186.50
Disclosure

SEC source: 0000899243-19-010428 · doc4.xml · nonDerivative · entry 3

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 538,406

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
April 09, 2019 Filed Apr 10, 2019 01:43 UTC
Maag PeterDirector · See Remarks
Exercise / conversionCommon Stock 35,381 $5.27 $186,457.87
Disclosure

SEC source: 0000899243-19-010428 · doc4.xml · nonDerivative · entry 2

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 536,151

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
April 09, 2019 Filed Apr 10, 2019 01:43 UTC
Maag PeterDirector · See Remarks
Exercise / conversionCommon Stock 42,364 $6.49 $274,942.36
Disclosure

SEC source: 0000899243-19-010428 · doc4.xml · nonDerivative · entry 1

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,770

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 20:27 UTC GrantCommon Stock 343 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-009900 · doc4.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,184

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
April 01, 2019 Filed Apr 4, 2019 00:32 UTC GrantCommon Stock 806 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-009905 · doc4.xml · nonDerivative · entry 1

Goldberg Michael · CIK 0001366412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,546

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
April 01, 2019 Filed Apr 4, 2019 00:27 UTC GrantCommon Stock 514 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-009901 · doc4.xml · nonDerivative · entry 1

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,967

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
March 21, 2019 Filed Mar 21, 2019 23:12 UTC OtherWarrant (right to buy) · Derivative 25,000 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0000899243-19-008750 · doc4.xml · derivative · entry 6

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2021-06-17

Read SEC document
March 21, 2019 Filed Mar 21, 2019 23:12 UTC OtherWarrant (right to buy) · Derivative 7,980 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0000899243-19-008750 · doc4.xml · derivative · entry 5

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,980 shares

Expires 2021-06-17

Read SEC document
March 21, 2019 Filed Mar 21, 2019 23:12 UTC OtherCommon Stock 25,000 $1.12 $28,000.00
Disclosure

SEC source: 0000899243-19-008750 · doc4.xml · nonDerivative · entry 2

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,453

Read SEC document
March 21, 2019 Filed Mar 21, 2019 23:12 UTC OtherCommon Stock 7,980 $1.12 $8,937.60
Disclosure

SEC source: 0000899243-19-008750 · doc4.xml · nonDerivative · entry 1

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,453

Read SEC document
March 20, 2019 Filed Mar 21, 2019 23:12 UTC PurchaseWarrant (right to buy) · Derivative 25,000 $36.14 Strike: $1.12 $903,500.00
Disclosure

SEC source: 0000899243-19-008750 · doc4.xml · derivative · entry 4

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2021-06-17

Read SEC document
March 20, 2019 Filed Mar 21, 2019 23:12 UTC PurchaseWarrant (right to buy) · Derivative 7,980 $36.14 Strike: $1.12 $288,397.20
Disclosure

SEC source: 0000899243-19-008750 · doc4.xml · derivative · entry 3

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,980

Underlying: Common Stock · 7,980 shares

Expires 2021-06-17

Read SEC document
March 14, 2019 Filed Mar 15, 2019 01:25 UTC SaleCommon Stock 50,000 $37.36 $1,867,825.00
Disclosure

SEC source: 0000899243-19-007817 · doc4.xml · nonDerivative · entry 1

Goldberg Michael · CIK 0001366412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,740

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.37 to $38.19, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.

Read SEC document
March 12, 2019 Filed Mar 12, 2019 21:09 UTC
Yee James PChief Medical Officer
SaleCommon Stock 7,598 $35.18 $267,282.44
Disclosure

SEC source: 0000899243-19-007399 · doc4.xml · nonDerivative · entry 1

Yee James P · CIK 0001421336 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,409

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.51 to $35.56, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.

Read SEC document
March 11, 2019 Filed Mar 12, 2019 01:15 UTC
Maag PeterDirector · See Remarks
SaleCommon Stock 50,000 $34.23 $1,711,280.00
Disclosure

SEC source: 0000899243-19-007157 · doc4.xml · nonDerivative · entry 1

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 458,406

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.695 to $34.84, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 18:56 UTC
Yee James PChief Medical Officer
Tax withholdingCommon Stock 3,685 $31.64 $116,593.40
Disclosure

SEC source: 0000899243-19-006264 · doc4.xml · nonDerivative · entry 2

Yee James P · CIK 0001421336 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,007

F2 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 18:56 UTC
Yee James PChief Medical Officer
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-006264 · doc4.xml · nonDerivative · entry 1

Yee James P · CIK 0001421336 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,692

F1 · shares: The reported securities were represented by restricted performance stock units that were granted on October 20, 2017, 100% of which vested on March 1, 2019 upon the achievement of the requisite performance criteria.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 23:57 UTC
Maag PeterDirector · See Remarks
Tax withholdingCommon Stock 22,311 $31.64 $705,920.04
Disclosure

SEC source: 0000899243-19-006266 · doc4.xml · nonDerivative · entry 2

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 508,406

F2 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 23:57 UTC
Maag PeterDirector · See Remarks
GrantCommon Stock 45,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-006266 · doc4.xml · nonDerivative · entry 1

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 530,717

F1 · shares: The reported securities were represented by restricted performance stock units that were granted on October 20, 2017, 100% of which vested on March 1, 2019 upon the achievement of the requisite performance criteria.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 23:56 UTC
Bell Michael BrianChief Financial Officer
SaleCommon Stock 13,000 $31.36 $407,742.40
Disclosure

SEC source: 0000899243-19-006263 · doc4.xml · nonDerivative · entry 3

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,290

F3 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.15 to $31.495, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 23:56 UTC
Bell Michael BrianChief Financial Officer
Tax withholdingCommon Stock 11,770 $31.64 $372,402.80
Disclosure

SEC source: 0000899243-19-006263 · doc4.xml · nonDerivative · entry 2

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,290

F2 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 23:56 UTC
Bell Michael BrianChief Financial Officer
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-006263 · doc4.xml · nonDerivative · entry 1

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,060

F1 · shares: The reported securities were represented by restricted performance stock units that were granted on October 20, 2017, 100% of which vested on March 1, 2019 upon the achievement of the requisite performance criteria.

Read SEC document
February 22, 2019 Filed Feb 22, 2019 21:36 UTC
King SashaChief Commercial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 7,500 $0.00 Strike: $5.90 $0.00
Disclosure

SEC source: 0000899243-19-004606 · doc4.xml · derivative · entry 3

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 7,500 shares

Expires 2027-10-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.